Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1181860747
rs1181860747
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE The Gly1057Asp polymorphism was not associated with insulin resistance or impaired insulin secretion in Finnish subjects with normal glucose tolerance (n = 295) or impaired glucose tolerance (n = 38). 11473060

2001

dbSNP: rs1217691063
rs1217691063
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE Individuals with a family history of diabetes or with risk factors such as obesity, hypertension, and impaired glucose tolerance should be screened for MTHFR C677T mutation and may be prescribed folic acid, vitamin B6, and vitamin B12 to assess if this helps in delaying the onset of diabetes. 21186995

2011

dbSNP: rs121909244
rs121909244
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE Nes<sup>Cre</sup>/PPARγ-P467L mice fed either control diet or high-fat diet displayed impaired glucose tolerance yet exhibited increased sensitivity to exogenous insulin and increased insulin receptor signaling in white adipose tissue, liver, and skeletal muscle. 27575030

2016

dbSNP: rs121912438
rs121912438
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE Using physiological tests and a biophysics approach based on nuclear magnetic resonance (NMR), we unexpectedly found that SOD1(G93A) ALS mice suffered from severe glucose intolerance, which was counteracted by high intensity swimming but not moderate intensity running exercise. 29104532

2017

dbSNP: rs1229984
rs1229984
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE Significant interactions were observed between alcohol and ADH1b (rs1229984) with respect to LDL and between alcohol and ALDH2 (rs886205) with respect to IGT/diabetes. 20700531

2010

dbSNP: rs13266634
rs13266634
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE And the pooled odds ratio (OR) for allelic frequency comparison showed that rs13266634 C/T polymorphism was also significantly associated with IGT: OR=1.15, 95% CI=1.06-1.26, P<0.001, P(heterogeneity)=0.364. 21131091

2011

dbSNP: rs13283456
rs13283456
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE The PTGES2 Arg298His polymorphism was reinvestigated in a population-based cross-sectional study (Cooperative Health Research in the Augsburg Region) consisting of 239 individuals with impaired glucose tolerance, 226 with type 2 diabetes, and 863 normoglycemic controls. 17566096

2007

dbSNP: rs137852787
rs137852787
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE The E224K mutation cosegregated with early-onset diabetes or impaired glucose tolerance in a large family, suggestive of the type 4 form of maturity-onset diabetes of the young rather than type 2 diabetes. 14764823

2004

dbSNP: rs1486559930
rs1486559930
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE Examination of the P322S/+ metabolic phenotype revealed late-onset glucose intolerance. 31439647

2019

dbSNP: rs1527483
rs1527483
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE To identify rs1049673 and rs1527483 in the CD36 gene conferring susceptibility to IFG/IGT and T2D, we conducted a case-control study in 1257 essential hypertension patients among the Han Chinese population (control: 676; IGT/IFG: 468; T2D: 113). 22869067

2012

dbSNP: rs16139
rs16139
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE The present study thus provides the evidence that Leu7Pro polymorphism in the NPY gene is associated with IGT and T2DM in Swedish men, and indicates that the NPY gene variations contribute to development of T2DM. 15926114

2005

dbSNP: rs1693482
rs1693482
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE The ADH1c (rs1693482) fast metabolizing CC genotype was associated with an increased risk of impaired glucose tolerance (IGT)/diabetes compared to the CT and TT genotypes. 20700531

2010

dbSNP: rs17446593
rs17446593
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE In the German subjects at increased risk for type 2 diabetes, SNPs rs2721068 and rs17446614 were significantly (P = 0.0045 and P = 0.0018, respectively) and SNPs rs17446593 and rs2297627 were nominally (P = 0.0091 and P = 0.0387, respectively) associated with beta-cell dysfunction. rs2721068, rs17446614, and rs2297627 were also nominally associated with impaired glucose tolerance (P = 0.0264, P = 0.0162, and P = 0.0221, respectively). 19141580

2009

dbSNP: rs17446614
rs17446614
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE In the German subjects at increased risk for type 2 diabetes, SNPs rs2721068 and rs17446614 were significantly (P = 0.0045 and P = 0.0018, respectively) and SNPs rs17446593 and rs2297627 were nominally (P = 0.0091 and P = 0.0387, respectively) associated with beta-cell dysfunction. rs2721068, rs17446614, and rs2297627 were also nominally associated with impaired glucose tolerance (P = 0.0264, P = 0.0162, and P = 0.0221, respectively). 19141580

2009

dbSNP: rs1799883
rs1799883
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE (1) The Ala54 and Thr54 allele frequencies in Chinese were 0.71 and 0.29 respectively; (2) The FABP2-Ala54Thr variation was neither associated with fasting and post-challenged plasma glucose levels nor with NIDDM; (3) This variation was neither associated with fasting lipid profile nor with obesity; (4) The IGT subjects with genotype Thr54(+) (Thr54 homozygotes and heterozygotes) had lower fasting, 2-hour and total C-peptide levels and smaller AUC representing lesser C-peptide secretion after glucose challenge than those with genotype Thr54(-) (Ala54 homozygotes) (P = 0.04, 0.03, 0.01 and 0.01 respectively). 11593593

1999

dbSNP: rs1799983
rs1799983
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE The eNOS G894T polymorphism appears to be predictive of persistent hyperglycemia in Chinese subjects with IGT. 16919532

2006

dbSNP: rs1799999
rs1799999
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE In conclusion, we found no evidence in Swedish men that the PP1ARE or the Asp905Tyr variants over a 20-year period predict the development of IGT or type 2 diabetes, but the PP1ARE polymorphism could have a higher penetrance in other populations. 10868947

2000

dbSNP: rs1800562
rs1800562
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE Allele frequencies of C282Y and H63D did not differ between diabetic and control groups nor among subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and diabetes. 12148086

2002

dbSNP: rs1801278
rs1801278
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE To assess the relevance of a Gly-->Arg substitution in codon 972 of the insulin receptor substrate-1 gene in impaired glucose tolerance (IGT) and NIDDM. 9589236

1998

dbSNP: rs1805094
rs1805094
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE In premenopausal women with IGT</span> (n = 65), associations were found with Lys(109)Arg and Lys(656)Asn for overall glucose response to the glucose load. 11443193

2001

dbSNP: rs1884614
rs1884614
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE In the P2 promoter, the htSNP rs1884614 showed borderline association with both type 2 diabetes (OR 1.40, P = 0.09) and the combined type 2 diabetes/IGT trait (1.35, P = 0.07). 15561969

2004

dbSNP: rs2073162
rs2073162
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE The same two markers together with rs2073162 associated with the conversion of IGT to T2D in men. 17495183

2007

dbSNP: rs2233580
rs2233580
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE In the logistic regression analysis, the most important factor predicting IGT and IR was older age of survivors (P=0.014 and P<0.001, respectively) whereas the PAX4 R192H mutation (rs2233580) was significantly associated with IGT after adjustment for age (P=0.043) (adjusted OR 5.28, 95% CI 1.06-26.40). 20485196

2010

dbSNP: rs2278426
rs2278426
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE The rates of T2D and IGT were greater in subjects with the R59W variant. 29397342

2019

dbSNP: rs2293855
rs2293855
CUI: C0271650
Disease: Impaired glucose tolerance
Impaired glucose tolerance
0.010 GeneticVariation BEFREE Moreover, the G allele of rs2293855 was associated with glucose intolerance (fasting glucose, P=0.012; glucose AUC, P=0.006; 2-h glucose, P=0.024); it is also associated with decreased indices of insulin sensitivity (fasting insulin, P=0.043; insulin sensitivity index composite, P=0.009; homeostasis model assessment of insulin resistance, HOMA-IR, P=0.008) and decreased indices of insulin secretion (HOMA of beta cell function, HOMA-B, P=0.028; insulinogenic index, P=0.003). 24937802

2014